Exact Sciences Corp. Company Profile (NASDAQ:EXAS)

About Exact Sciences Corp.

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some forms of cancer. The Company's product pipeline includes Lung Cancer Nodules, Pancreatic Cancer Screening, Esophageal Cancer Screening, Lung Cancer Pipeline, Pancreatic Cancer Pipeline and Esophageal Cancer Pipeline. It has developed a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a non invasive stool based deoxyribonucleic acid (DNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. The United States Food and Drug Administration (FDA) approved Cologuard for use as sDNA non-invasive colorectal cancer screening test. Cologuard is available through healthcare providers. It also focused on developing its pipeline for future products and services.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Laboratories & Research
Sub-Industry: Biotechnology
Exchange: NASDAQ
Symbol: EXAS
CUSIP: 30063P10

Key Metrics:

Previous Close: $18.57
50 Day Moving Average: $19.70
200 Day Moving Average: $11.95
52-Week Range: $4.67 - $22.80
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -12.46
P/E Growth: -0.48
Market Cap: $1.83B
Outstanding Shares: 98,332,000
Beta: 1.07

Profitability:

Net Margins: -277.74%
Return on Equity: -57.16%
Return on Assets: -51.12%

Debt:

Debt-to-Equity Ratio: 0.02%
Current Ratio: 8.71%
Quick Ratio: 8.41%

Additional Links:

Companies Related to Exact Sciences Corp.:

Consensus Ratings for Exact Sciences Corp. (NASDAQ:EXAS) (?)

Ratings Breakdown:	7 Hold Ratings, 6 Buy Ratings
Consensus Rating:	Hold (Score: 2.46)
Consensus Price Target:	$16.12 (13.22% downside)

Analysts' Ratings History for Exact Sciences Corp. (NASDAQ:EXAS)

Show:

Date	Firm	Action	Rating	Price Target
9/4/2016	Craig Hallum	Set Price Target	Buy	$26.00
8/15/2016	Goldman Sachs Group Inc.	Boost Price Target	Neutral	$16.00 -> $18.00
8/1/2016	Roth Capital	Reiterated Rating	Hold	$11.00 -> $15.00
7/31/2016	Robert W. Baird	Reiterated Rating	Outperform	$18.00
7/31/2016	BTIG Research	Reiterated Rating	Buy	$20.00
7/27/2016	Jefferies Group	Boost Price Target	Buy -> Buy	$13.00 -> $20.00
7/27/2016	Benchmark Co.	Lower Price Target	Hold	$14.00 -> $9.00
7/27/2016	Mizuho	Boost Price Target	Neutral	$10.00 -> $15.00
7/26/2016	Canaccord Genuity	Reiterated Rating	Buy
7/15/2016	William Blair	Reiterated Rating	Outperform	$29.00
2/25/2016	Stephens	Downgrade	Overweight -> Equal Weight
11/24/2015	Lake Street Capital	Reiterated Rating	Hold	$12.00 -> $7.00
10/30/2015	Wedbush	Lower Price Target		$7.00 -> $6.50
5/5/2015	JMP Securities	Boost Price Target	Outperform	$27.00 -> $31.00
10/13/2014	Maxim Group	Boost Price Target	Sell	$8.00 -> $12.00

(Data available from 10/1/2014 forward)

Earnings History for Exact Sciences Corp. (NASDAQ:EXAS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/27/2016
7/26/2016	Q216	($0.55)	($0.46)	$18.54 million	$21.20 million	View	Listen
5/3/2016	Q116	($0.52)	($0.49)	$15.17 million	$14.80 million	View	N/A
2/24/2016	Q415	($0.47)	($0.41)	$14.96 million	$14.40 million	View	Listen
10/29/2015	Q315	($0.44)	($0.45)	$12.56 million	$12.60 million	View	Listen
7/20/2015	Q215	($0.45)	($0.44)	$7.96 million	$8.10 million	View	Listen
5/4/2015	Q115	($0.41)	($0.40)	$4.11 million	$4.30 million	View	N/A
2/24/2015	Q414	($0.04)	($0.38)	$19.90 million	$1.15 million	View	N/A
10/27/2014	Q314	($0.32)	($0.39)	$0.13 million		View	Listen
7/22/2014	Q214	($0.25)	($0.24)	$0.03 million		View	N/A
5/1/2014	Q114	($0.19)	($0.23)	$0.40 million	$0.30 million	View	N/A
2/20/2014	Q413	($0.19)	($0.17)	$1.02 million	$1.00 million	View	N/A
10/29/2013	Q313	($0.18)	($0.16)	$1.02 million	$1.00 million	View	N/A
7/23/2013	Q2 2013	($0.18)	($0.19)	$1.02 million	$1.00 million	View	N/A
5/1/2013	Q1 2013	($0.20)	($0.17)	$1.02 million	$1.00 million	View	N/A
2/20/2013	Q4 2012	($0.18)	($0.22)	$1.04 million	$1.00 million	View	N/A
10/30/2012	Q312	($0.21)	($0.21)	$1.03 million	$1.04 million	View	N/A
7/25/2012		($0.20)	($0.26)			View	N/A
5/1/2012		($0.18)	($0.19)			View	N/A
2/23/2012		($0.17)	($0.18)			View	N/A
11/3/2011		($0.15)	($0.15)			View	N/A
8/2/2011		($0.10)	($0.13)			View	N/A
5/3/2011		($0.09)	($0.08)			View	N/A
2/15/2011		($0.08)	($0.08)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Exact Sciences Corp. (NASDAQ:EXAS)

Current Year EPS Consensus Estimate: $-1.8 EPS
Next Year EPS Consensus Estimate: $-1.49 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	6	($0.54)	($0.46)	($0.51)
Q2 2016	4	($0.56)	($0.54)	($0.55)
Q3 2016	4	($0.55)	($0.47)	($0.52)
Q4 2016	4	($0.55)	($0.40)	($0.50)
Q1 2017	2	($0.44)	($0.35)	($0.40)
Q2 2017	2	($0.42)	($0.34)	($0.38)
Q3 2017	2	($0.40)	($0.35)	($0.38)
Q4 2017	2	($0.38)	($0.36)	($0.37)

(Data provided by Zacks Investment Research)

Dividend History for Exact Sciences Corp. (NASDAQ:EXAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Exact Sciences Corp. (NASDAQ:EXAS)

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 86.91%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/1/2016	Lionel Sterling	Director	Buy	5,000	$18.10	$90,500.00
8/3/2016	Katherine S Zanotti	Director	Buy	3,380	$17.93	$60,603.40
7/26/2016	Graham Peter Lidgard	Insider	Sell	7,383	$14.82	$109,416.06
7/26/2016	Maneesh Arora	COO	Sell	7,359	$14.82	$109,060.38
4/1/2016	D Scott Coward	SVP	Sell	1,685	$6.62	$11,154.70
3/10/2016	D Scott Coward	SVP	Sell	2,175	$6.05	$13,158.75
3/10/2016	Graham Peter Lidgard	Insider	Sell	3,041	$6.05	$18,398.05
3/10/2016	Maneesh Arora	COO	Sell	4,042	$6.05	$24,454.10
3/8/2016	James Edward Doyle	Director	Buy	5,000	$6.43	$32,150.00
3/3/2016	Katherine S Napier	Director	Buy	3,775	$5.38	$20,309.50
3/1/2016	Kevin T Conroy	CEO	Buy	50,000	$5.00	$250,000.00
2/26/2016	Kevin T Conroy	CEO	Sell	6,895	$5.81	$40,059.95
2/25/2016	Graham Peter Lidgard	Insider	Sell	2,997	$5.52	$16,543.44
2/25/2016	Maneesh Arora	COO	Sell	4,099	$5.52	$22,626.48
2/23/2016	Graham Peter Lidgard	Insider	Sell	2,411	$6.39	$15,406.29
2/23/2016	Kevin T Conroy	CEO	Sell	6,866	$6.39	$43,873.74
2/23/2016	Maneesh Arora	COO	Sell	2,556	$6.39	$16,332.84
1/11/2016	David Thompson	Director	Buy	15,000	$6.99	$104,850.00
2/26/2015	Graham Peter Lidgard	Director	Sell	3,938	$23.44	$92,306.72
2/26/2015	Kevin T Conroy	CEO	Sell	8,425	$23.44	$197,482.00
2/26/2015	Maneesh Arora	COO	Sell	3,895	$23.44	$91,298.80
2/24/2015	Graham Peter Lidgard	Director	Sell	4,037	$22.90	$92,447.30
2/24/2015	Kevin T Conroy	CEO	Sell	9,798	$22.90	$224,374.20
2/24/2015	Maneesh Arora	COO	Sell	2,995	$22.90	$68,585.50
1/2/2015	Graham Peter Lidgard	Insider	Sell	3,363	$26.72	$89,859.36
1/2/2015	Kevin T Conroy	CEO	Sell	9,484	$26.72	$253,412.48
1/2/2015	Maneesh Arora	COO	Sell	2,495	$26.72	$66,666.40
10/29/2014	Graham Peter Lidgard	Insider	Sell	8,015	$24.68	$197,810.20
7/25/2014	Graham Peter Lidgard	VP	Sell	11,081	$15.99	$177,185.19
7/25/2014	Kevin T Conroy	CEO	Sell	11,336	$15.99	$181,262.64
7/25/2014	Maneesh Arora	COO	Sell	9,291	$15.99	$148,563.09
5/5/2014	William Megan	SVP	Buy	10,000	$11.79	$117,900.00
2/24/2014	Graham Peter Lidgard	VP	Sell	3,160	$14.07	$44,461.20
2/24/2014	Kevin Conroy	CEO	Sell	8,708	$14.07	$122,521.56
2/24/2014	Maneesh Arora	COO	Sell	2,662	$14.07	$37,454.34
1/2/2014	Graham Peter Lidgard	VP	Sell	10,288	$11.96	$123,044.48
1/2/2014	Kevin Conroy	CEO	Sell	26,379	$11.96	$315,492.84
1/2/2014	Maneesh Arora	COO	Sell	8,627	$11.96	$103,178.92
10/28/2013	Graham Peter Lidgard	VP	Sell	7,430	$11.07	$82,250.10
9/20/2013	Sally Crawford	Director	Sell	25,000	$12.19	$304,750.00
11/2/2012	Kevin T Conroy	CEO	Buy	2,000	$9.13	$18,260.00
11/2/2012	Maneesh Arora	CFO	Buy	1,000	$9.04	$9,040.00
11/1/2012	Lionel Sterling	Director	Buy	5,500	$9.08	$49,940.00

(Data available from 1/1/2013 forward)

Latest Headlines for Exact Sciences Corp. (NASDAQ:EXAS)

Date	Headline
	Latest Analyst Ratings For EXACT Sciences Corporation (EXAS) (NASDAQ:EXAS) www.desotoedge.com - September 30 at 5:17 PM
	EXACT Sciences Corporation (NASDAQ:EXAS): Price Target Stands At $15.777 (NASDAQ:EXAS) www.realistinvestor.com - September 30 at 5:17 PM
	EXACT Sciences Corporation (NASDAQ:EXAS): Price Target Stands At $15.777 - RealistInvestor.com (NASDAQ:EXAS) www.realistinvestor.com - September 30 at 5:17 PM
	EXACT Sciences Corporation (NASDAQ:EXAS) & Prudential Financial Inc (NYSE:PRU) Stocks to Keep Your Eyes on (NASDAQ:EXAS) www.newsismoney.com - September 30 at 5:17 PM
	EXACT Sciences Corp. breached its 50 day moving average in a Bearish Manner : EXAS-US : September 30, 2016 (NASDAQ:EXAS) www.capitalcube.com - September 30 at 10:03 AM
	Exact Sciences to host third-quarter 2016 results webcast and call - PR Newswire (press release) (NASDAQ:EXAS) www.prnewswire.com - September 29 at 9:56 AM
	Latest Analyst Ratings For EXACT Sciences Corporation (EXAS) - The De Soto Edge (NASDAQ:EXAS) desotoedge.com - September 29 at 9:56 AM
	EXACT Sciences Corporation (NASDAQ:EXAS) & International Paper Co (NYSE:IP) Stocks to Keep Your Eyes on - Money News (NASDAQ:EXAS) www.newsismoney.com - September 29 at 9:56 AM
	ETF’s with exposure to EXACT Sciences Corp. : September 29, 2016 (NASDAQ:EXAS) www.capitalcube.com - September 29 at 9:56 AM
	Mayo, Exact Sciences Laud Cologuard’s Success After Long Fight For Acceptance (NASDAQ:EXAS) tcbmag.com - September 28 at 4:47 PM
	EXACT Sciences Corporation (NASDAQ:EXAS) & Accenture Plc (NYSE:ACN) Stocks to Keep Your Eyes on (NASDAQ:EXAS) www.newsismoney.com - September 28 at 4:47 PM
	Exact Sciences to host third-quarter 2016 results webcast and call (NASDAQ:EXAS) finance.yahoo.com - September 28 at 9:50 AM
	HC Stocks Newsbeat! EXACT Sciences Corporation (EXAS), Medtronic PLC (NYSE:MDT) - share market updates (press release) (NASDAQ:EXAS) sharemarketupdates.com - September 27 at 4:57 PM
	EXACT Sciences Corporation (NASDAQ:EXAS) Analyst Opinion - The Independent Republic (NASDAQ:EXAS) theindependentrepublic.com - September 23 at 4:43 PM
	EXACT Sciences Corporation (NASDAQ:EXAS) & Targa Resources Corp (NYSE:TRGP) News Recap - Money News (NASDAQ:EXAS) www.newsismoney.com - September 23 at 4:43 PM
	EXACT Sciences (EXAS) Shares March Higher, Can It Continue? (NASDAQ:EXAS) finance.yahoo.com - September 23 at 4:43 PM
	Analysts Valuations For Two Stocks: CBRE Group Inc (NYSE:CBG), EXACT Sciences Corporation (NASDAQ:EXAS) - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 21 at 5:26 PM
	Exact Sciences Corporation's (EXAS): Trader's Spotlight - Hot Stocks Point (NASDAQ:EXAS) www.hotstockspoint.com - September 21 at 5:26 PM
	Exact Sciences Corporation (NASDAQ:EXAS) Upcoming Earnings ... - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 20 at 8:46 AM
	Exact Sciences Corporation's (EXAS): Market Traders Recap - Hot Stocks Point (NASDAQ:EXAS) www.hotstockspoint.com - September 20 at 8:46 AM
	HC Stocks Momentum! EXACT Sciences Corporation (EXAS), Opko Health Inc. (NASDAQ:OPK) - share market updates (press release) (NASDAQ:EXAS) sharemarketupdates.com - September 19 at 3:51 PM
	Analysts Valuations For Two Stocks: EXACT Sciences Corporation (NASDAQ:EXAS), Umpqua Holdings Corp ... - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 19 at 3:51 PM
	Research Analysts Set EXACT Sciences Corporation (NASDAQ:EXAS)'s Price Target At $15.777 - RealistInvestor.com (NASDAQ:EXAS) www.realistinvestor.com - September 16 at 4:49 PM
	HC Stocks Zone= Valeant Pharmaceuticals Intl Inc (VRX), EXACT ... - share market updates (press release) (NASDAQ:EXAS) sharemarketupdates.com - September 14 at 5:01 PM
	Dialectic Capital Management Lp adds EXACT Sciences Corporation (EXAS) to its portfolio (NASDAQ:EXAS) www.nationaldailypress.com - September 12 at 4:45 PM
	EXACT Sciences Corporation (NASDAQ:EXAS), Anthem Inc (NYSE ... - share market updates (press release) (NASDAQ:EXAS) sharemarketupdates.com - September 12 at 9:48 AM
	Analysts Valuations For Two Stocks: EXACT Sciences Corporation (NASDAQ:EXAS), Total System Services, Inc ... - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 12 at 9:48 AM
	Analysts Valuations For Two Stocks: EXACT Sciences Corporation (NASDAQ:EXAS), Apartment Investment and ... - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 9 at 9:46 AM
	Analysts Valuations For Two Stocks: EXACT Sciences Corporation (NASDAQ:EXAS), H & R Block Inc (NYSE:HRB) - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 9 at 9:46 AM
	Healthcare Stocks Under Review -- Exact Sciences, Great Basin Scientific, Agilent Technologies, and Thermo Fisher Scientific (NASDAQ:EXAS) www.kswo.com - September 8 at 8:48 AM
	Analysts Valuations For Two Stocks: EXACT Sciences Corporation (NASDAQ:EXAS), SunPower Corporation ... - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 6 at 9:44 AM
	EXACT Sciences Corporation (NASDAQ:EXAS) Is Expected To Post EPS Of $-0.34 (NASDAQ:EXAS) www.realistinvestor.com - September 4 at 4:35 PM
	Exact Sciences Corporation's (EXAS): Hot Stock - Hot Stocks Point - Hot Stocks Point (NASDAQ:EXAS) www.hotstockspoint.com - September 3 at 4:36 PM
	News Buzz: NextEra Energy Inc (NYSE:NEE), EXACT Sciences Corporation (NASDAQ:EXAS), TASER International ... - NYSE Journal (press release) (NASDAQ:EXAS) stockznews.com - September 1 at 6:35 AM
	Analysts Valuations For Two Stocks: Veeva Systems Inc (NYSE:VEEV), EXACT Sciences Corporation (NASDAQ:EXAS) - The Voice Registrar (NASDAQ:EXAS) voiceregistrar.com - September 1 at 6:35 AM
	EXACT Sciences : Elk Creek Partners adds EXACT Sciences Corporation (EXAS) to its portfolio (NASDAQ:EXAS) www.4-traders.com - August 31 at 4:50 PM
	Exact Sciences to participate in the Baird 2016 Global Healthcare Conference (NASDAQ:EXAS) finance.yahoo.com - August 30 at 8:01 AM
	ETF’s with exposure to EXACT Sciences Corp. : August 29, 2016 (NASDAQ:EXAS) www.capitalcube.com - August 29 at 4:52 PM
	Exact Sciences (EXAS): Strong Industry, Solid Earnings Estimate Revisions (NASDAQ:EXAS) www.zacks.com - August 29 at 9:34 AM
	Exact Sciences Corp (EXAS): Billionaire David E. Shaw's D E Shaw Ups Its Stake - Insider Monkey (blog) (NASDAQ:EXAS) www.insidermonkey.com - August 27 at 4:40 PM
	Healthcare Stocks on the Move: EXACT Sciences Corporation ... - Post Registrar (NASDAQ:EXAS) postregistrar.com - August 23 at 10:02 PM
	Smaller Biotechs Surging to New Highs (NASDAQ:EXAS) www.investopedia.com - August 23 at 5:01 PM
	Analysts Set $15.777 Price Target For EXACT Sciences Corporation (NASDAQ:EXAS) - RealistInvestor.com (NASDAQ:EXAS) www.realistinvestor.com - August 20 at 4:52 PM
	Analysts Set $15.777 Price Target For EXACT Sciences Corporation (NASDAQ:EXAS) (NASDAQ:EXAS) www.realistinvestor.com - August 19 at 4:52 PM
	ETF’s with exposure to EXACT Sciences Corp. : August 18, 2016 (NASDAQ:EXAS) www.capitalcube.com - August 18 at 10:16 PM
	Exact Sciences (EXAS) Announces Updated CMS Evidence of Coverage for Cologuard - StreetInsider.com (NASDAQ:EXAS) www.streetinsider.com - August 15 at 12:09 PM
	CMS Affirms Cologuard® Covered Every Three Years for Medicare Advantage Beneficiaries without Cost Sharing (NASDAQ:EXAS) finance.yahoo.com - August 15 at 12:09 PM
	Better Buy: Exact Sciences Corporation vs. Myriad Genetics (NASDAQ:EXAS) www.fool.com - August 15 at 12:09 PM
	Exact Sciences (EXAS) Announces Expansion of Cologuard Coverage with Florida Blue, HCSC (NASDAQ:EXAS) www.streetinsider.com - August 11 at 5:05 PM
	EXACT Sciences Corporation (NASDAQ:EXAS): We Made 140% Profit In 7 Weeks In 4 Multiple Swing Trades, Join Us (NASDAQ:EXAS) www.marketnewscall.com - August 11 at 5:05 PM